Taylor J, Pardo B, Hulme S, Bouey J, Greenfield V, Zhang S, Kilmer B. Illicit synthetic opioid consumption in Asia and the Pacific: assessing the risks of a potential outbreak. Drug Alcohol Depend. 2021;220:108500.
Liu SY, Yu WJ, Wang YR, Shao XT, Wang DG. Tracing consumption patterns of stimulants, opioids, and ketamine in China by wastewater-based epidemiology. Environ Sci Pollut Res Int. 2021;28(13):16754–66.
Volkow ND, Jones EB, Einstein EB, Wargo EM. Prevention and treatment of opioid misuse and addiction: a review. JAMA Psychiatry. 2019;76(2):208–16.
Lee JD, Nunes EV Jr, Novo P, Bachrach K, Bailey GL, Bhatt S, Farkas S, Fishman M, Gauthier P, Hodgkins CC, et al. Comparative effectiveness of extended-release naltrexone versus buprenorphine-naloxone for opioid relapse prevention (X:BOT): a multicentre, open-label, randomised controlled trial. Lancet. 2018;391(10118):309–18.
Sullivan MA, Bisaga A, Pavlicova M, Carpenter KM, Choi CJ, Mishlen K, Levin FR, Mariani JJ, Nunes EV. A randomized trial comparing extended-release injectable suspension and oral naltrexone, both combined with behavioral therapy, for the treatment of opioid use disorder. Am J Psychiatry. 2019;176(2):129–37.
Nunes EV, Gordon M, Friedmann PD, Fishman MJ, Lee JD, Chen DT, Hu MC, Boney TY, Wilson D, O’Brien CP. Relapse to opioid use disorder after inpatient treatment: protective effect of injection naltrexone. J Subst Abuse Treat. 2018;85:49–55.
Chen T, Zhong N, Du J, Li Z, Zhao Y, Sun H, Chen Z, Jiang H, Zhao M. Polydrug use patterns and their impact on relapse among heroin-dependent patients in Shanghai, China. Addiction. 2019;114(2):259–67.
Groman SM, Jentsch JD. Cognitive control and the dopamine D₂-like receptor: a dimensional understanding of addiction. Depress Anxiety. 2012;29(4):295–306.
Kalivas PW, Volkow ND. The neural basis of addiction: a pathology of motivation and choice. Am J Psychiatry. 2005;162(8):1403–13.
El-Sheikh Sel G, Bashir TZ. High-risk relapse situations and self-efficacy: comparison between alcoholics and heroin addicts. Addict Behav. 2004;29(4):753–8.
Llorente JM, Fernández C, Gutiérrez M. Prediction of relapse among heroin users treated in Spanish therapeutic communities. A comparison of different models. Subst Use Misuse. 2000;35(11):1537–50.
Schmidt A, Borgwardt S, Gerber H, Schmid O, Wiesbeck GA, Riecher-Rössler A, Bendfeldt K, Smieskova R, Lang UE, Rubia K, et al. Altered prefrontal connectivity after acute heroin administration during cognitive control. Int J Neuropsychopharmacol. 2014;17(9):1375–85.
Beran MJ, Menzel CR, Parrish AE, Perdue BM, Sayers K, Smith JD, Washburn DA. Primate cognition: attention, episodic memory, prospective memory, self-control, and metacognition as examples of cognitive control in nonhuman primates. Wiley Interdiscip Rev Cogn Sci. 2016;7(5):294–316.
Article PubMed PubMed Central Google Scholar
Blume AW, Alan Marlatt G. The role of executive cognitive functions in changing substance use: what we know and what we need to know. Ann Behav Med. 2009;37(2):117–25.
Domínguez-Salas S, Díaz-Batanero C, Lozano-Rojas OM, Verdejo-García A. Impact of general cognition and executive function deficits on addiction treatment outcomes: systematic review and discussion of neurocognitive pathways. Neurosci Biobehav Rev. 2016;71:772–801.
Henry JD. Prospective memory impairment in neurological disorders: implications and management. Nat Rev Neurol. 2021;17(5):297–307.
Terrett G, McLennan SN, Henry JD, Biernacki K, Mercuri K, Curran HV, Rendell PG. Prospective memory impairment in long-term opiate users. Psychopharmacology. 2014;231(13):2623–32.
Mercuri K, Terrett G, Henry JD, Bailey PE, Curran HV, Rendell PG. Episodic foresight deficits in long-term opiate users. Psychopharmacology. 2015;232(7):1337–45.
Liao DL, Huang CY, Hu S, Fang SC, Wu CS, Chen WT, Lee TS, Chen PC, Li CS. Cognitive control in opioid dependence and methadone maintenance treatment. PLoS One. 2014;9(4): e94589.
Article PubMed PubMed Central Google Scholar
Redzepagic S, Ladas AI. Prospective memory, sustained attention and response inhibition in poly-substance users stable on methadone maintenance treatment. Subst Use Misuse. 2023;58(3):397–405.
Zhong H, Dang J, Huo Z, Ma Z, Chen J, Huang Y, Zhu Y, Li M. Effects of medial prefrontal cortex 5-HT(7) receptor knockdown on cognitive control after acute heroin administration. Brain Res. 2018;1678:419–31.
Schmidt A, Walter M, Gerber H, Schmid O, Smieskova R, Bendfeldt K, Wiesbeck GA, Riecher-Rössler A, Lang UE, Rubia K, et al. Inferior frontal cortex modulation with an acute dose of heroin during cognitive control. Neuropsychopharmacology. 2013;38(11):2231–9.
Article PubMed PubMed Central Google Scholar
Jia TY, Niu XT. Analysis on the image of ming-style chair based on eye movement tracking technique. Packag Eng. 2018;39.
Rayner K, Smith TJ, Malcolm GL, Henderson JM. Eye movements and visual encoding during scene perception. Psychol Sci. 2009;20(1):6–10.
Alcorn JL 3rd, Strickland JC, Lile JA, Stoops WW, Rush CR. Acute methylphenidate administration reduces cocaine-cue attentional bias. Prog Neuropsychopharmacol Biol Psychiatry. 2020;103:109974.
Hadjiefthyvoulou F, Fisk JE, Montgomery C, Bridges N. Everyday and prospective memory deficits in ecstasy/polydrug users. J Psychopharmacol. 2011;25(4):453–64.
Roth R M, Isquith P K, Gioia G A. Behavior Rating Inventory of Executive Function®--Adult Version. Arch Clin Neuropsychol. 2005.
Zhao W, Wei T, Zhou R, Wang Y, Wang Y, Ren Z, Shao W, Luo H, Zhou Y, Chen N, et al. The influence of online game behaviors on the emotional state and executive function of college students in China. Front Psychiatry. 2021;12:713364.
Article PubMed PubMed Central Google Scholar
Crawford JR, Henry JD, Ward AL, Blake J. The Prospective and Retrospective Memory Questionnaire (PRMQ): latent structure, normative data and discrepancy analysis for proxy-ratings. Br J Clin Psychol. 2006;45(Pt 1):83–104.
Yang TX, Wang Y, Wang Y, Su XM, Ni K, Lui SSY, Chan RCK. Validity and normative data of the Chinese Prospective and Retrospective Memory Questionnaire (PRMQ) across adolescence, adults and elderly people. Memory. 2022;30(3):344–53.
Ma B, Mei D, Wang F, Liu Y, Zhou W. Cognitive enhancers as a treatment for heroin relapse and addiction. Pharmacol Res. 2019;141:378–83.
Niendam TA, Laird AR, Ray KL, Dean YM, Glahn DC, Carter CS. Meta-analytic evidence for a superordinate cognitive control network subserving diverse executive functions. Cogn Affect Behav Neurosci. 2012;12(2):241–68.
Article PubMed PubMed Central Google Scholar
Perone S, Simmering VR, Buss AT. A dynamical reconceptualization of executive-function development. Perspect Psychol Sci. 2021;16(6):1198–208.
Article PubMed PubMed Central Google Scholar
Gruber SA, Silveri MM, Yurgelun-Todd DA. Neuropsychological consequences of opiate use. Neuropsychol Rev. 2007;17(3):299–315.
Feil J, Sheppard D, Fitzgerald PB, Yücel M, Lubman DI, Bradshaw JL. Addiction, compulsive drug seeking, and the role of frontostriatal mechanisms in regulating inhibitory control. Neurosci Biobehav Rev. 2010;35(2):248–75.
Harocopos A, Nolan ML, Goldstein GP, Mantha S, O’Neill M, Paone D. Implementing a methadone delivery system in New York City in response to COVID-19. Am J Public Health. 2021;111(12):2115–7.
Comments (0)